GeoVax Labs Inc. (NASDAQ: GOVX) stock jumped 42.86% on Friday to $3.90 against a previous-day closing price of $2.73. With 113.42 million shares changed hands, the volume of the stock remained heavier than its average volume of 22.65 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.3000 whereas the lowest price it dropped to was $3.5603. The 52-week range on GOVX shows that it touched its highest point at $7.50 and its lowest point at $0.55 during that stretch. It currently has a 1-year price target of $6.00. Beta for the stock currently stands at 2.59.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GOVX was up-trending over the past week, with a rise of 145.28%, but this was up by 369.82% over a month. Three-month performance surged to 393.67% while six-month performance rose 72.57%. The stock lost -10.76% in the past year, while it has gained 7.73% so far this year. A look at the trailing 12-month EPS for GOVX yields -3.01 with Next year EPS estimates of -0.86. For the next quarter, that number is -0.32. This implies an EPS growth rate of -42.40% for this year and 9.50% for next year.
Float and Shares Shorts:
On Apr 28, 2022, short shares totaled 0.33 million, which was 3.50% higher than short shares on Mar 30, 2022. In addition to Mr. David Alan Dodd as the firm’s Chairman, Pres & CEO, Mr. Mark W. Reynolds CPA, CPA serves as its CFO & Corp. Sec.
Through their ownership of 15.65% of GOVX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 6.78% of GOVX, in contrast to 2.51% held by mutual funds. Shares owned by individuals account for 2.21%. As the largest shareholder in GOVX with 3.47% of the stake, Armistice Capital LLC holds 435,150 shares worth 435,150. A second-largest stockholder of GOVX, The Vanguard Group, Inc., holds 256,224 shares, controlling over 2.04% of the firm’s shares. Cavalry Fund I Management LLC is the third largest shareholder in GOVX, holding 219,335 shares or 1.75% stake. With a 1.32% stake in GOVX, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 165,070 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.73% of GOVX stock, is the second-largest Mutual Fund holder. It holds 91,154 shares valued at 75658.0. Fidelity Extended Market Index Fu holds 0.26% of the stake in GOVX, owning 32,008 shares worth 26567.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GOVX since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With GOVX analysts setting a high price target of $6.00 and a low target of $6.00, the average target price over the next 12 months is $6.00. Based on these targets, GOVX could surge 53.85% to reach the target high and rise by 53.85% to reach the target low. Reaching the average price target will result in a growth of 53.85% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. GOVX will report FY 2022 earnings on 03/24/2023. Analysts have provided yearly estimates in a range of -$0.97 being high and -$0.97 being low. For GOVX, this leads to a yearly average estimate of -$0.97. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. GeoVax Labs Inc. surprised analysts by -$0.11 when it reported -$0.34 EPS against a consensus estimate of -$0.23. The surprise factor in the prior quarter was -$1.83. Based on analyst estimates, the high estimate for the next quarter is -$0.30 and the low estimate is -$0.30. The average estimate for the next quarter is thus -$0.30.
Summary of Insider Activity:
Insiders traded GOVX stock several times over the past three months with 5 Buys and 0 Sells. In these transactions, 30,185 shares were bought while 0 shares were sold. The number of buy transactions has increased to 5 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 30,185 while 0 shares were sold.